Booz Allen Hamilton Revenue Falls 3.9% but FY2027 Guidance Rises
Booz Allen Hamilton raised FY2027 revenue guidance following earnings, but TTM revenue fell 3.9% YoY to $11.0bn, with analysts citing fair value at $87 on 12.9x forward P/E.
Booz Allen Hamilton Revenue Falls 3.9% but FY2027 Guidance Rises
NEW YORK, November 3 —
Booz Allen Hamilton Holding Corporation (BAH) reported TTM revenue of $11.0bn, a 3.9% YoY contraction, while simultaneously raising its FY2027 revenue guidance.
- TTM revenue $11.0bn, down 3.9% YoY; trailing EPS $6.44; FCF $789mn
- At $87 and 12.9x fwd P/E, the valuation prices in the guidance lift without leaving room for a re-rating
- Q3 FY2027 organic revenue growth is the confirmation print; a positive turn breaks the range
Shrinking Revenue at a Defense IT Prime Demands an Explanation
Booz Allen Hamilton (BAH) generates roughly $11bn annually through national security, defense, and civil agency contracts. A YoY top-line decline of that magnitude while U.S. defense budgets sit at cycle highs is not a macro story. It is a contract-flow story. Something specific rolled off the books, and management's decision to raise FY2027 guidance in the same release signals it expects the gap to close.
$789mn Free Cash Flow Suggests the Lost Work Was Low-Margin
A 7.2% FCF margin on $11bn in professional services revenue is notably clean. Government contractors running cost-plus and fixed-price work typically see cash yields compress in revenue-down years as fixed costs eat into billings. The fact that BAH held $789mn in FCF while contracting at that same rate YoY implies the contracts exiting the backlog were thinner than the work replacing them. That is a qualitative upgrade of the revenue base, even if the headline number looks worse. It is the one line in this filing that argues the bull case is not purely aspirational.
12.9x Forward P/E Reflects Transition, Not a Discount
At $87 and trailing EPS of $6.44, BAH trades at a 12.9x forward multiple, a level that reflects the ongoing revenue contraction rather than a mispriced opportunity. Investors are pricing in the guidance lift without yet seeing organic growth confirm it. The stock will stay range-bound until quarterly organic revenue growth turns positive. A continued decline in Q3 FY2027 would put the guidance target in question and compress the multiple further. Use the DCF calculator to stress-test the guidance range against different revenue recovery scenarios.
FY2027 Guidance Higher: One Number Will Settle It
Raising multi-year revenue guidance after a year of contraction requires contract visibility that is not yet externally verifiable. The proof point is Q3 FY2027 organic revenue growth. A positive organic print confirms new contract wins are replacing what rolled off. If organic growth stays negative while headline revenue recovers, the guidance lift is a timing story rather than a structural one, and the fair-value assessment holds but nothing more. That is the number to watch, not the quarterly EPS beat or miss.
For a full breakdown of BAH's fundamentals, valuation metrics, and revenue trends, visit the Booz Allen Hamilton stock page at Basis Report.
Basis Report is independent research for informational purposes. It is not investment advice and not a recommendation to buy or sell any security.
Booz Allen Hamilton reported earnings with updated FY2027 revenue guidance, with analysts assessing the stock as fairly valued at current levels.